Status:
COMPLETED
Generalized Hypersensitivity in Patients With Fibromyalgia Syndrome
Lead Sponsor:
University of Florida
Conditions:
Fibromyalgia
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Fibromyalgia (FM) is a chronic musculoskeletal pain disorder with unknown causes. Our previous studies showed abnormal sensations of second pain (wind-up), indicating central hypersensitivity as an im...
Detailed Description
Increasing evidence has shown that the hypersensitivity of FM is not limited to painful stimuli but seems to extend to non-painful stimuli as well. These stimuli include smell, taste, touch, light, an...
Eligibility Criteria
Inclusion
- Individuals diagnosed with FM will have pain of \> 3 months and meet the 1990 and 2011 Diagnostic Criteria for FM (ACR)
- Healthy, pain-free age and sex matched controls without chronic pain
Exclusion
- Presence of chronic disease (e.g. cancer, cardiovascular disease, liver disease, kidney disease, diabetes, etc.).
- FM patients must be willing to discontinue or hold their FM related medications for a minimum of one day prior to the visit.
- Significant vision loss not corrected by eye wear
- Family history of photosensitive epilepsy
Key Trial Info
Start Date :
August 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 11 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04415866
Start Date
August 28 2020
End Date
December 11 2020
Last Update
March 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32610